Drugs - Real World Outcomes

ISSN: 2199-1154 (Print) 2198-9788 (Online)

Description

Drugs - Real World Outcomes targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'. Drugs-Real World Outcomes has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.

 
Articles published in Drugs – Real World Outcomes may be accompanied by plain language summaries, to assist patients, caregivers  and others in understanding important medical advances.

Upon acceptance for publication, manuscripts submitted to the journal will be subject to an article processing charge (APC) of US$2,200. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of the APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.

Browse Volumes & Issues